特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
960604

神経痛治療の世界市場:治療タイプ別、適応症別、流通チャネル別の市場調査と2025年までの予測

Neuralgia Treatment Market Research Report by Treatment Type, by Indication, by Distribution Channel - Global Forecast to 2025 - Cumulative Impact of COVID-19

出版日: | 発行: 360iResearch LLP | ページ情報: 英文 150 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.58円
神経痛治療の世界市場:治療タイプ別、適応症別、流通チャネル別の市場調査と2025年までの予測
出版日: 2020年09月15日
発行: 360iResearch LLP
ページ情報: 英文 150 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の神経痛治療市場は、2019年の6億9,167万米ドルから2025年末には13億131万米ドルに拡大すると予測されており、この間のCAGRは11.10%になると予測されています。

神経痛には、糖尿病性神経障害、肋間神経痛、後頭神経痛、末梢神経痛、帯状疱疹後神経痛、三叉神経痛などがあり、治療には、抗けいれん薬や三環系抗うつ薬などによる薬物療法、バルーン圧迫、グリセロール注射、微小血管減圧術、高周波熱損傷、定位放射線手術などの外科手術が用いられます。

当レポートは、世界の神経痛治療市場を調査したもので、市場の概要と力学、治療タイプ別、適応症別、流通チャネル別、地域別の市場分析、競合情勢、企業プロファイルなどの情報を提供しています。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場の力学

  • イントロダクション
  • 成長促進要因
    • 高齢化人口の増加による神経痛発生率の上昇
    • 神経痛治療製品の認知度を高めるための各国政府の取り組み
  • 抑制要因
    • 神経痛治療に関連する高額な費用
  • 市場機会
    • 技術の進歩による薬物や手術の必要性の低下
    • 新興経済圏での外科的治療や薬理学的治療の開発
  • 課題
    • 医薬品の副作用

第6章 市場の考察

  • ポーターのファイブフォース分析
  • COVID-19の累積的影響
  • クライアントのカスタマイズ
    • 規制の枠組み

第7章 治療タイプ別の市場

  • イントロダクション
  • 薬剤ベース
    • 抗けいれん薬
    • 三環系抗うつ薬
  • 手術
    • バルーン圧縮
    • グリセロール注射
    • 微小血管減圧
    • 高周波熱損傷
    • 定位放射線手術

第8章 適応症別の市場

  • イントロダクション
  • 糖尿病性神経障害
  • 肋間神経痛
  • 後頭神経痛
  • 末梢神経痛
  • 帯状疱疹後神経痛
  • 三叉神経痛

第9章 流通チャネル別の市場

  • イントロダクション
  • ドラッグストア
  • 病院薬局
  • オンライン薬局
  • 小売薬局

第10章 南北アメリカ市場

  • イントロダクション
  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋市場

  • イントロダクション
  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • 韓国
  • タイ

第12章 欧州、中東・アフリカ市場

  • イントロダクション
  • フランス
  • ドイツ
  • イタリア
  • オランダ
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリックス
    • 四象限分析
    • 事業戦略
    • 製品の充足度
  • 市場ランキング分析
  • 市場シェア分析
  • 競合シナリオ
    • 合併と買収
    • 合意、協力、提携
    • 新製品の発売と強化
    • 投資と資金調達
    • 発注、承認、拡大

第14章 企業プロファイル

  • Biogen Inc.
  • Cadila Healthcare Limited
  • Cephalon Inc.
  • GlaxoSmithKline PLC
  • GLENMARK PHARMS LTD.
  • H. Lundbeck A/S
  • Janssen Pharmaceuticals, Inc.
  • Johnson & Johnson Services, Inc.
  • LGM Pharma LLC
  • Lupin Limited
  • Novartis AG
  • Pfizer Inc.
  • Psychotropics India Limited
  • Takeda Pharmaceutical Company Limited
  • Teikoku Pharma USA, Inc.
  • Teva Pharmaceuticals Ltd.
  • Torrent Pharmaceuticals Ltd.
  • UCB Group

第15章 付録

図表

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEURALGIA TREATMENT MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL NEURALGIA TREATMENT MARKET: RESEARCH EXECUTION
  • FIGURE 3. GLOBAL NEURALGIA TREATMENT MARKET SIZE, 2019 VS 2025 (USD MILLION)
  • FIGURE 4. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2019 VS 2025 (USD MILLION)
  • FIGURE 5. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019 VS 2025 (USD MILLION)
  • FIGURE 6. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019 VS 2025 (USD MILLION)
  • FIGURE 7. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  • FIGURE 8. GLOBAL NEURALGIA TREATMENT MARKET SIZE, 2017-2025 (USD MILLION)
  • FIGURE 9. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
  • FIGURE 10. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  • FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 12. GLOBAL NEURALGIA TREATMENT MARKET: MARKET DYNAMICS
  • FIGURE 13. GLOBAL NEURALGIA TREATMENT MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 14. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019 VS 2025 (%)
  • FIGURE 15. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019 VS 2025 (USD MILLION)
  • FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025
  • FIGURE 17. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DRUG BASED, 2019 VS 2025 (USD MILLION)
  • FIGURE 18. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY ANTICONVULSANT MEDICINES, 2019 VS 2025 (USD MILLION)
  • FIGURE 19. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TRICYCLIC ANTIDEPRESSANTS, 2019 VS 2025 (USD MILLION)
  • FIGURE 20. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2019 VS 2025 (USD MILLION)
  • FIGURE 21. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY BALLOON COMPRESSION, 2019 VS 2025 (USD MILLION)
  • FIGURE 22. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY GLYCEROL INJECTION, 2019 VS 2025 (USD MILLION)
  • FIGURE 23. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY MICROVASCULAR DECOMPRESSION, 2019 VS 2025 (USD MILLION)
  • FIGURE 24. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY RADIOFREQUENCY THERMAL LESIONING, 2019 VS 2025 (USD MILLION)
  • FIGURE 25. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY STEREOTACTIC RADIOSURGERY, 2019 VS 2025 (USD MILLION)
  • FIGURE 26. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2019 VS 2025 (%)
  • FIGURE 27. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2019 VS 2025 (USD MILLION)
  • FIGURE 28. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2025
  • FIGURE 29. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DIABETIC NEUROPATHY, 2019 VS 2025 (USD MILLION)
  • FIGURE 30. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY INTERCOSTAL NEURALGIA, 2019 VS 2025 (USD MILLION)
  • FIGURE 31. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY OCCIPITAL NEURALGIA, 2019 VS 2025 (USD MILLION)
  • FIGURE 32. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY PERIPHERAL NEURALGIA, 2019 VS 2025 (USD MILLION)
  • FIGURE 33. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY POSTHERPETIC NEURALGIA, 2019 VS 2025 (USD MILLION)
  • FIGURE 34. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TRIGEMINAL NEURALGIA, 2019 VS 2025 (USD MILLION)
  • FIGURE 35. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019 VS 2025 (%)
  • FIGURE 36. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019 VS 2025 (USD MILLION)
  • FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025
  • FIGURE 38. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DRUG STORES, 2019 VS 2025 (USD MILLION)
  • FIGURE 39. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2019 VS 2025 (USD MILLION)
  • FIGURE 40. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2019 VS 2025 (USD MILLION)
  • FIGURE 41. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2019 VS 2025 (USD MILLION)
  • FIGURE 42. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
  • FIGURE 43. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  • FIGURE 44. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 45. ARGENTINA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 46. BRAZIL NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 47. CANADA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 48. MEXICO NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 49. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 50. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
  • FIGURE 51. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  • FIGURE 52. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 53. AUSTRALIA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 54. CHINA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 55. INDIA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 56. INDONESIA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 57. JAPAN NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 58. MALAYSIA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 59. PHILIPPINES NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 60. SOUTH KOREA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 61. THAILAND NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 62. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
  • FIGURE 63. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  • FIGURE 64. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 65. FRANCE NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 66. GERMANY NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 67. ITALY NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 68. NETHERLANDS NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 69. QATAR NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 70. RUSSIA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 71. SAUDI ARABIA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 72. SOUTH AFRICA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 73. SPAIN NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 74. UNITED ARAB EMIRATES NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 75. UNITED KINGDOM NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • FIGURE 76. GLOBAL NEURALGIA TREATMENT MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
  • FIGURE 77. GLOBAL NEURALGIA TREATMENT MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
  • FIGURE 78. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL NEURALGIA TREATMENT MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL NEURALGIA TREATMENT MARKET SIZE, 2017-2025 (USD MILLION)
  • TABLE 2. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 3. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  • TABLE 4. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DRUG BASED, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 5. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY ANTICONVULSANT MEDICINES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 6. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TRICYCLIC ANTIDEPRESSANTS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 7. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 8. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY BALLOON COMPRESSION, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 9. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY GLYCEROL INJECTION, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 10. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY MICROVASCULAR DECOMPRESSION, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 11. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY RADIOFREQUENCY THERMAL LESIONING, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 12. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY STEREOTACTIC RADIOSURGERY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 13. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  • TABLE 14. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DIABETIC NEUROPATHY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 15. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY INTERCOSTAL NEURALGIA, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 16. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY OCCIPITAL NEURALGIA, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 17. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY PERIPHERAL NEURALGIA, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 18. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY POSTHERPETIC NEURALGIA, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 19. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TRIGEMINAL NEURALGIA, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 20. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  • TABLE 21. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DRUG STORES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 22. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 23. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 24. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 25. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 26. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  • TABLE 27. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  • TABLE 28. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  • TABLE 29. ARGENTINA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  • TABLE 30. ARGENTINA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  • TABLE 31. ARGENTINA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  • TABLE 32. BRAZIL NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  • TABLE 33. BRAZIL NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  • TABLE 34. BRAZIL NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  • TABLE 35. CANADA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  • TABLE 36. CANADA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  • TABLE 37. CANADA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  • TABLE 38. MEXICO NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  • TABLE 39. MEXICO NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  • TABLE 40. MEXICO NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  • TABLE 41. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  • TABLE 42. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  • TABLE 43. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  • TABLE 48. AUSTRALIA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  • TABLE 49. AUSTRALIA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  • TABLE 50. AUSTRALIA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  • TABLE 51. CHINA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  • TABLE 52. CHINA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  • TABLE 53. CHINA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  • TABLE 54. INDIA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  • TABLE 55. INDIA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  • TABLE 56. INDIA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  • TABLE 57. INDONESIA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  • TABLE 58. INDONESIA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  • TABLE 59. INDONESIA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  • TABLE 60. JAPAN NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  • TABLE 61. JAPAN NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  • TABLE 62. JAPAN NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  • TABLE 63. MALAYSIA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  • TABLE 64. MALAYSIA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  • TABLE 65. MALAYSIA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  • TABLE 66. PHILIPPINES NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  • TABLE 67. PHILIPPINES NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  • TABLE 68. PHILIPPINES NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  • TABLE 69. SOUTH KOREA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  • TABLE 70. SOUTH KOREA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  • TABLE 71. SOUTH KOREA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  • TABLE 72. THAILAND NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  • TABLE 73. THAILAND NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  • TABLE 74. THAILAND NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  • TABLE 79. FRANCE NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  • TABLE 80. FRANCE NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  • TABLE 81. FRANCE NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  • TABLE 82. GERMANY NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  • TABLE 83. GERMANY NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  • TABLE 84. GERMANY NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  • TABLE 85. ITALY NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  • TABLE 86. ITALY NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  • TABLE 87. ITALY NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  • TABLE 88. NETHERLANDS NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  • TABLE 89. NETHERLANDS NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  • TABLE 90. NETHERLANDS NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  • TABLE 91. QATAR NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  • TABLE 92. QATAR NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  • TABLE 93. QATAR NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  • TABLE 94. RUSSIA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  • TABLE 95. RUSSIA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  • TABLE 96. RUSSIA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  • TABLE 97. SAUDI ARABIA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  • TABLE 98. SAUDI ARABIA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  • TABLE 99. SAUDI ARABIA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  • TABLE 100. SOUTH AFRICA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  • TABLE 101. SOUTH AFRICA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  • TABLE 102. SOUTH AFRICA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  • TABLE 103. SPAIN NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  • TABLE 104. SPAIN NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  • TABLE 105. SPAIN NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  • TABLE 106. UNITED ARAB EMIRATES NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  • TABLE 107. UNITED ARAB EMIRATES NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  • TABLE 108. UNITED ARAB EMIRATES NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  • TABLE 109. UNITED KINGDOM NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  • TABLE 110. UNITED KINGDOM NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  • TABLE 111. UNITED KINGDOM NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  • TABLE 112. GLOBAL NEURALGIA TREATMENT MARKET: SCORES
  • TABLE 113. GLOBAL NEURALGIA TREATMENT MARKET: BUSINESS STRATEGY
  • TABLE 114. GLOBAL NEURALGIA TREATMENT MARKET: PRODUCT SATISFACTION
  • TABLE 115. GLOBAL NEURALGIA TREATMENT MARKET: RANKING
  • TABLE 116. GLOBAL NEURALGIA TREATMENT MARKET: MERGER & ACQUISITION
  • TABLE 117. GLOBAL NEURALGIA TREATMENT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 118. GLOBAL NEURALGIA TREATMENT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 119. GLOBAL NEURALGIA TREATMENT MARKET: INVESTMENT & FUNDING
  • TABLE 120. GLOBAL NEURALGIA TREATMENT MARKET: AWARD, RECOGNITION, & EXPANSION
目次
Product Code: MRR-50AD649

Title:
Neuralgia Treatment Market Research Report by Treatment Type (Drug Based and Surgery), by Indication (Diabetic Neuropathy, Intercostal Neuralgia, Occipital Neuralgia, Peripheral Neuralgia, and Postherpetic Neuralgia), by Distribution Channel - Global Forecast to 2025 - Cumulative Impact of COVID-19.

The Global Neuralgia Treatment Market is expected to grow from USD 691.67 Million in 2019 to USD 1,301.31 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 11.10%.

Market Segmentation & Coverage:

This research report categorizes the Neuralgia Treatment to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Treatment Type, the Neuralgia Treatment Market studied across Drug Based and Surgery. The Drug Based further studied across Anticonvulsant Medicines and Tricyclic Antidepressants. The Surgery further studied across Balloon Compression, Glycerol Injection, Microvascular Decompression, Radiofrequency Thermal Lesioning, and Stereotactic Radiosurgery.

Based on Indication, the Neuralgia Treatment Market studied across Diabetic Neuropathy, Intercostal Neuralgia, Occipital Neuralgia, Peripheral Neuralgia, Postherpetic Neuralgia, and Trigeminal Neuralgia.

Based on Distribution Channel, the Neuralgia Treatment Market studied across Drug Stores, Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.

"The Asia-Pacific is projected to witness the highest growth during the forecast period"

Based on Geography, the Neuralgia Treatment Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Americas commanded the largest size in the Neuralgia Treatment Market in 2019. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Neuralgia Treatment Market including Biogen Inc., Cadila Healthcare Limited, Cephalon Inc., GlaxoSmithKline PLC, GLENMARK PHARMS LTD., H. Lundbeck A/S, Janssen Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., LGM Pharma LLC, Lupin Limited, Novartis AG, Pfizer Inc., Psychotropics India Limited, Takeda Pharmaceutical Company Limited, Teikoku Pharma USA, Inc., Teva Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., and UCB Group.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Neuralgia Treatment Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Neuralgia Treatment Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Neuralgia Treatment Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Neuralgia Treatment Market?
  • 4. What is the competitive strategic window for opportunities in the Global Neuralgia Treatment Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Neuralgia Treatment Market?
  • 6. What are the modes and strategic moves considered suitable for entering the Global Neuralgia Treatment Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Research Process
    • 2.1.1. Define: Research Objective
    • 2.1.2. Determine: Research Design
    • 2.1.3. Prepare: Research Instrument
    • 2.1.4. Collect: Data Source
    • 2.1.5. Analyze: Data Interpretation
    • 2.1.6. Formulate: Data Verification
    • 2.1.7. Publish: Research Report
    • 2.1.8. Repeat: Report Update
  • 2.2. Research Execution
    • 2.2.1. Initiation: Research Process
    • 2.2.2. Planning: Develop Research Plan
    • 2.2.3. Execution: Conduct Research
    • 2.2.4. Verification: Finding & Analysis
    • 2.2.5. Publication: Research Report
  • 2.3. Research Outcome

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Indication Outlook
  • 3.4. Distribution Channel Outlook
  • 3.5. Treatment Type Outlook
  • 3.6. Geography Outlook
  • 3.7. Competitor Outlook

4. Market Overview

  • 4.1. Introduction

5. Market Dynamics

  • 5.1. Introduction
  • 5.2. Drivers
    • 5.2.1. Increasing incidences of neuralgia due to the rise in the aging population
    • 5.2.2. Government initiatives to spread awareness regarding neuralgia treatment products
  • 5.3. Restraints
    • 5.3.1. High-cost associated with the treatment of neuralgia
  • 5.4. Opportunities
    • 5.4.1. Technological advancement eliminates the need for drugs and surgery
    • 5.4.2. Developing surgical and pharmacological treatment in developing economies
  • 5.5. Challenges
    • 5.5.1. Persistent side effects from medications

6. Market Insights

  • 6.1. Porters Five Forces Analysis
    • 6.1.1. Threat of New Entrants
    • 6.1.2. Threat of Substitutes
    • 6.1.3. Bargaining Power of Customers
    • 6.1.4. Bargaining Power of Suppliers
    • 6.1.5. Industry Rivalry
  • 6.2. Cumulative Impact of COVID-19
  • 6.3. Client Customizations
    • 6.3.1. Regulatory Framework

7. Global Neuralgia Treatment Market, By Treatment Type

  • 7.1. Introduction
  • 7.2. Drug Based
    • 7.2.1. Anticonvulsant Medicines
    • 7.2.2. Tricyclic Antidepressants
  • 7.3. Surgery
    • 7.3.1. Balloon Compression
    • 7.3.2. Glycerol Injection
    • 7.3.3. Microvascular Decompression
    • 7.3.4. Radiofrequency Thermal Lesioning
    • 7.3.5. Stereotactic Radiosurgery

8. Global Neuralgia Treatment Market, By Indication

  • 8.1. Introduction
  • 8.2. Diabetic Neuropathy
  • 8.3. Intercostal Neuralgia
  • 8.4. Occipital Neuralgia
  • 8.5. Peripheral Neuralgia
  • 8.6. Postherpetic Neuralgia
  • 8.7. Trigeminal Neuralgia

9. Global Neuralgia Treatment Market, By Distribution Channel

  • 9.1. Introduction
  • 9.2. Drug Stores
  • 9.3. Hospital Pharmacies
  • 9.4. Online Pharmacies
  • 9.5. Retail Pharmacies

10. Americas Neuralgia Treatment Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Neuralgia Treatment Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. South Korea
  • 11.10. Thailand

12. Europe, Middle East & Africa Neuralgia Treatment Market

  • 12.1. Introduction
  • 12.2. France
  • 12.3. Germany
  • 12.4. Italy
  • 12.5. Netherlands
  • 12.6. Qatar
  • 12.7. Russia
  • 12.8. Saudi Arabia
  • 12.9. South Africa
  • 12.10. Spain
  • 12.11. United Arab Emirates
  • 12.12. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
    • 13.1.1. Quadrants
    • 13.1.2. Business Strategy
    • 13.1.3. Product Satisfaction
  • 13.2. Market Ranking Analysis
  • 13.3. Market Share Analysis
  • 13.4. Competitive Scenario
    • 13.4.1. Merger & Acquisition
    • 13.4.2. Agreement, Collaboration, & Partnership
    • 13.4.3. New Product Launch & Enhancement
    • 13.4.4. Investment & Funding
    • 13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles

  • 14.1. Biogen Inc.
  • 14.2. Cadila Healthcare Limited
  • 14.3. Cephalon Inc.
  • 14.4. GlaxoSmithKline PLC
  • 14.5. GLENMARK PHARMS LTD.
  • 14.6. H. Lundbeck A/S
  • 14.7. Janssen Pharmaceuticals, Inc.
  • 14.8. Johnson & Johnson Services, Inc.
  • 14.9. LGM Pharma LLC
  • 14.10. Lupin Limited
  • 14.11. Novartis AG
  • 14.12. Pfizer Inc.
  • 14.13. Psychotropics India Limited
  • 14.14. Takeda Pharmaceutical Company Limited
  • 14.15. Teikoku Pharma USA, Inc.
  • 14.16. Teva Pharmaceuticals Ltd.
  • 14.17. Torrent Pharmaceuticals Ltd.
  • 14.18. UCB Group

15. Appendix

  • 15.1. Discussion Guide
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.